NO20080650L - Forbindelser omfattende DMXAA for behandling av kreft - Google Patents
Forbindelser omfattende DMXAA for behandling av kreftInfo
- Publication number
- NO20080650L NO20080650L NO20080650A NO20080650A NO20080650L NO 20080650 L NO20080650 L NO 20080650L NO 20080650 A NO20080650 A NO 20080650A NO 20080650 A NO20080650 A NO 20080650A NO 20080650 L NO20080650 L NO 20080650L
- Authority
- NO
- Norway
- Prior art keywords
- dmxaa
- cancer
- treatment
- combinations
- compounds
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/39541—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against normal tissues, cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Oppfinnelsen angår kombinasjoner av klassen xanthenonetansyrer med formel (I), slik som 5,6-dimetylxanthenon-4-etansyre (DMXAA), og EGFR-signaleringsvei-inhibitorer. Nærmere bestemt er oppfinnelsen relatert til bruk av slike kombinasjoner i behandling av kreft, og farmasøytiske blandinger som inneholder slike kombinasjoner. (I)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0517387.7A GB0517387D0 (en) | 2005-08-26 | 2005-08-26 | Combinations for the treatment of cancer |
PCT/GB2006/003207 WO2007023307A1 (en) | 2005-08-26 | 2006-08-25 | Combinations comprising dmxaa for the treatment of cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20080650L true NO20080650L (no) | 2008-05-13 |
Family
ID=35198384
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20080650A NO20080650L (no) | 2005-08-26 | 2008-02-06 | Forbindelser omfattende DMXAA for behandling av kreft |
Country Status (16)
Country | Link |
---|---|
US (1) | US20100104565A1 (no) |
EP (1) | EP1931331A1 (no) |
JP (1) | JP2009506020A (no) |
KR (1) | KR20080048488A (no) |
CN (1) | CN101296695A (no) |
AU (1) | AU2006283376A1 (no) |
BR (1) | BRPI0614964A2 (no) |
CA (1) | CA2620447A1 (no) |
EC (1) | ECSP088242A (no) |
GB (1) | GB0517387D0 (no) |
IL (1) | IL189377A0 (no) |
MA (1) | MA29784B1 (no) |
NO (1) | NO20080650L (no) |
RU (1) | RU2404765C2 (no) |
TN (1) | TNSN08057A1 (no) |
WO (1) | WO2007023307A1 (no) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1311262A4 (en) | 2000-07-28 | 2005-06-01 | Cancer Rec Tech Ltd | COMBINED TREATMENT AGAINST CANCER |
GB0121285D0 (en) | 2001-09-03 | 2001-10-24 | Cancer Res Ventures Ltd | Anti-cancer combinations |
GB2386836B (en) | 2002-03-22 | 2006-07-26 | Cancer Res Ventures Ltd | Anti-cancer combinations |
GB2394658A (en) | 2002-11-01 | 2004-05-05 | Cancer Rec Tech Ltd | Oral anti-cancer composition |
ES2529790T3 (es) | 2007-04-13 | 2015-02-25 | Dana-Farber Cancer Institute, Inc. | Métodos de tratamiento de cáncer resistente a agentes terapéuticos de ERBB |
US8287346B2 (en) * | 2008-11-03 | 2012-10-16 | Cfph, Llc | Late game series information change |
WO2015077354A1 (en) * | 2013-11-19 | 2015-05-28 | The University Of Chicago | Use of sting agonist as cancer treatment |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0121285D0 (en) * | 2001-09-03 | 2001-10-24 | Cancer Res Ventures Ltd | Anti-cancer combinations |
-
2005
- 2005-08-26 GB GBGB0517387.7A patent/GB0517387D0/en not_active Ceased
-
2006
- 2006-08-25 RU RU2008111493/15A patent/RU2404765C2/ru not_active IP Right Cessation
- 2006-08-25 EP EP06765343A patent/EP1931331A1/en not_active Withdrawn
- 2006-08-25 CA CA002620447A patent/CA2620447A1/en not_active Abandoned
- 2006-08-25 BR BRPI0614964A patent/BRPI0614964A2/pt not_active IP Right Cessation
- 2006-08-25 KR KR1020087006685A patent/KR20080048488A/ko not_active Application Discontinuation
- 2006-08-25 WO PCT/GB2006/003207 patent/WO2007023307A1/en active Application Filing
- 2006-08-25 CN CNA2006800403862A patent/CN101296695A/zh active Pending
- 2006-08-25 US US12/064,632 patent/US20100104565A1/en not_active Abandoned
- 2006-08-25 AU AU2006283376A patent/AU2006283376A1/en not_active Abandoned
- 2006-08-25 JP JP2008527518A patent/JP2009506020A/ja active Pending
-
2008
- 2008-02-06 TN TNP2008000057A patent/TNSN08057A1/en unknown
- 2008-02-06 NO NO20080650A patent/NO20080650L/no not_active Application Discontinuation
- 2008-02-07 IL IL189377A patent/IL189377A0/en unknown
- 2008-03-05 EC EC2008008242A patent/ECSP088242A/es unknown
- 2008-03-17 MA MA30753A patent/MA29784B1/fr unknown
Also Published As
Publication number | Publication date |
---|---|
GB0517387D0 (en) | 2005-10-05 |
TNSN08057A1 (en) | 2009-07-14 |
IL189377A0 (en) | 2008-06-05 |
MA29784B1 (fr) | 2008-09-01 |
AU2006283376A1 (en) | 2007-03-01 |
RU2404765C2 (ru) | 2010-11-27 |
EP1931331A1 (en) | 2008-06-18 |
KR20080048488A (ko) | 2008-06-02 |
CN101296695A (zh) | 2008-10-29 |
BRPI0614964A2 (pt) | 2016-09-13 |
JP2009506020A (ja) | 2009-02-12 |
WO2007023307A1 (en) | 2007-03-01 |
ECSP088242A (es) | 2008-08-29 |
RU2008111493A (ru) | 2009-10-10 |
US20100104565A1 (en) | 2010-04-29 |
CA2620447A1 (en) | 2007-03-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20063821L (no) | Kinolinderivater for anvendelse som mykobakterielle inhibitorer | |
NO20063449L (no) | Substituerte heterocykler og deres anvendelse | |
SE0301010D0 (sv) | Novel compounds | |
EA200970156A1 (ru) | Пиридизиноновые производные | |
SE0301009D0 (sv) | Novel compounds | |
NO20073791L (no) | Pyrazolylaminopyridinderivater anvendbare som kinaseinhibitorer | |
UA107783C2 (en) | Isoindoline compounds for use in treating cancer | |
UA86591C2 (ru) | Пирролодигидроизохинолины как ингибиторы pde10, фармацевтическая композиция на их основе | |
EA200802050A1 (ru) | Новые гетероарилзамещенные ариламинопиридиновые производные в качестве мек ингибиторов | |
NO20075647L (no) | Kjemiske forbindelser | |
EA200870380A1 (ru) | Аминотетрагидропираны в качестве ингибиторов дипептидилпептидазы-vi для лечения или предупреждения диабета | |
TW200738659A (en) | Novel compounds | |
NO20080650L (no) | Forbindelser omfattende DMXAA for behandling av kreft | |
NO20056192L (no) | Kapaseinhibitorer og anvendelse derav | |
NO20085212L (no) | Nye pyridinanaloger | |
ATE538651T1 (de) | Spiropiperidininhibitoren von beta-secretase zur behandlung von alzheimer-krankheit | |
TW200745122A (en) | New compounds I | |
CY1111327T1 (el) | Υποκατεστημενα παραγωγα κυκλοεξυλοξεικου οξεος | |
EA201201550A1 (ru) | Производные альфа-кетоамидов в качестве ингибиторов цистеинпротеаз | |
ATE462703T1 (de) | Bicyclononen-derivate als renin-inhibitoren | |
DK1745010T3 (da) | Substituerede cyklohexyl-1,4-diaminderivater | |
TW200745133A (en) | New compounds II | |
TW200624429A (en) | Novel cysteine protease inhibitors | |
EA200800203A1 (ru) | Замещенные изотопами ингибиторы протонного насоса | |
IL191670A0 (en) | Compounds for the inhibition of apoptosis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |